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The performance of 99rTTc Stealth® liposomes was investigated in 
various rat models. Methods: Preformed polyethyleneglycol-con- 
taining liposomes with encapsulated reduced glutathione, were 
radiolabeled using the lipophilic 99mTc-HMPAO. The labeled lipo­
somes were intravenously administered to rats with focal S. aureus 
or E. coli infection, or turpentine-induced inflammation. For compar­
ison, Tc-99m-nanocolloid- and 99mTc-labeled nonspecific IgG were 
tested. In rats with Pneumocystis carinii pneumonia (PCP), Tc-99m- 
liposomes were directly compared to In-111 labeled nonspecific 
IgG. Results: Technetium-99m-liposomes accumulated in the in­
fectious and inflammatory muscle foci over 24 hr (0.59% injected 
dose per gram tissue (%ID/g) for E. coli; 0.98 %ID/g for S. aureus; 
1.18 %ID/g for turpentine). Abscess-to-muscle ratios increased to 
values as high as 24.0, 41.7 and 44.5 for the respective models at
24 hr postinjection. Technetium-99m-liposomes visualized the foci 
as early as 1 hr postinjection. Technetium-99m-lgG visualized S. 
aureus infection, but abscess-to-muscle ratios and abscess uptake 
at the later time points were significantly lower. Technetium-99m- 
nanocolloid failed to visualize any of the muscle foci. In PCP 
however, 99mTc-liposomes did not show preferential localization in 
the infection. The control agent 1111n-IgG showed a significant, 
two-fold increase in lung uptake. Conclusion: Technetium-99m- 
Stealth® liposomes preferentially accumulated in abscesses, leading 
to very high target-to-nontarget ratios. This property appears to be 
related to a process based on uptake of long-circulating particles. In 
a specific type of infection, i.e. PCP, 99mTc-liposomes did not 
accumulate in diseased lung tissue, thus mimicking the in vivo 
behavior of labeled leukocytes.
Key Words: polyethyleen glycol; immunoglobulin; technetium-99m- 
liposomes; indium-111-IgG; infection imaging; inflammation; Pneu­
mocystis carinii
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Im a g in g  infection and inflammation at early time points with 
convenient radiophannaceuticals approaches the clinician's 
concept o f  optimal imaging o f  infectious and inflammatory 
disease (J ). Since none o f  the currently available radiopharma­
ceuticals is ideal with regard to biodistribution, pharmacokinet­
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ics or accumulation in a focus, both preclinical and clinical 
efforts are made to develop an agent that meets these goals. One 
o f  the promising, new agents for scintigraphic detection o 
infection and inflammation is radiolabeled liposomes. Lipo­
somes consist o f  lipid bilayer membranes, enclosing aqueous 
compartments in which aqueous labels can be entrapped. In the 
past liposomes have been widely studied for achieving con- 
troled drug delivery and for imaging purposes (2 -5) .  However, 
these conventional liposomes are rapidly cleared from the 
circulation by phagocytic cells o f  the mononuclear phagocyte 
system (MPS) (6). Therefore, their use for diagnostic imaging 
is limited as the efficient MPS uptake competes with accumu­
lation at the target site. Development o f  new liposome formu­
lations characterized by prolonged circulation time was a 
significant step forward. The so-called sterically stabilized, or 
Stealth® (Liposome Technology, Inc., Menlo Park, CA), lipo­
somes have been shown to preferentially localize at diseased 
sites (7,#). In Stealth® liposomes, polyethylene glycol (PEG) is 
incorporated in the phospholipid bilayer, thereby drastically 
reducing the recognition o f  the liposomes by the MPS and thus 
increasing circulatory half-life. Recently, we have demonstrated 
excellent targeting o f  experimental focal infection with " ' i n ­
labeled Stealth® liposomes (9). When abscess accumulation 
and biodistribution are favorable, a y9mTc label is to be 
preferred over 11'in. In this study, we evaluated gg,11Tc-labeled 
Stealth® liposomes. Applicability o f  the yymTc label and the 
performance in several infection and inflammation models were 
studied. The performance o f  " mTe-liposomes was compared to 
other reagents used in clinical practice.
MATERIALS AND METHODS
Animal Models
Muscle Infection/Inflammation. A calf muscle abscess was 
induced in young, male, randomly-bred Wistar rats (body 
weight 200-220  g). After ether anesthesia, approximately 2 X 
10s colony-forming units (CFU o f  Staphyloccoccus aureus or
1 X 10y CFU o f  Escherichia coli in 0.1 ml 50:50% suspension 
o f  autologous blood and normal saline was injected in the left 
calf muscle ( 1 0 ). Sterile inflammation was induced by injection 
o f  0.15 ml o f  turpentine in the left calf muscle o f  ether-
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anaesthetized rats. Twenty-four hours after the inoculation, 
when swelling o f  the muscle was apparent, the respective 
iadiopharrnaceuticals were injected via the tail vein.
Pneumocystis Carinii Pneumonia. Young female, randomly- 
bred Sprague-Dawley rats (body weight 150-175 g) were 
mmunosuppressed by weekly subcutaneous injections o f
25 mg hydrocortisone and an 8% protein restricted diet. 
Vmoxicillin (1 mg/ml) was added to the drinking water to 
prevent bacterial infections. Pneumocystis carinii pneumonia 
PCP) was induced by close cohabitation with P. carinii- 
nfected rats for 4 wk. Viral co-infection was excluded by 
egular serological screening on common rodent viruses. PCP 
nfection was confirmed and bacterial co-infection excluded by 
nicroscopic examination o f  Giemsa-stained smears o f  the cut 
surface o f  the lung.
iadiopharrnaceuticals
Technetium-99m-Labeled Liposomes. We used partially hy­
drogenated egg-phosphatidylcholine with an iodine value o f  40 
(PHEPC) ( / / ) .  The PEG 1900 derivative o f  distearoylphos- 
phatidylethanolamine (PEG-DSPE) was donated by Liposome 
Technology, Inc. (Menlo Park, CA) and prepared as described 
previously (12) .  Cholesterol and glutathione were obtained 
commercially.
A chloroform/methanol mixture (10/1, v/v) containing PEG- 
DSPE, PHEPC and cholesterol was prepared in a molar ratio of 
0.15:1.85:1. A lipid film was formed by rotary evaporation 
followed by high vacuum to remove residual organic solvent. 
The film was hydrated at room temperature in 50 mM  glutathi­
one in HEPES buffer (10 mM  HEPES, 135 m M  NaCl at pH 7.4) 
at an initial phospholipid concentration o f  120 mM.  The 
resulting dispersion was passed through a microfluidizer. Un­
entrapped glutathione was removed by gel filtration. The 
particle size distribution was determined by dynamic light 
scattering. The mean size o f  the liposomes was 80 -100  nm.
Preformed glutathione-containing liposomes were labeled by 
transporting 9 mTc as a lipophilic gg,11Tc-hexamethylpropylene- 
amine oxime (HMPAO) complex through the bilayer. The 
,t,mTc-HMPAO is subsequently irreversibly trapped in the 
internal aqueous phase due to reduction by the encapsulated 
glutathione (13) .  One milligram HMPAO was incubated with 
2.5 GBq lH>mTc-pertechnetate. The liposomes were incubated 
for 15 min at room temperature with 1 MBq i;t,mTc-HMPAO per 
jiimole phospholipid. Labeling efficiency was between 60 and 
70%. Removal o f  unencapsulated " mTc-HMPAO was achieved 
by gel filtration on a Econo Pac 10DG column (Bio-Rad, 
Richmond, CA) with 5% glucose solution as the eluent.
A commercially available kit for 99mTc-IgG (Technescan- 
HIG, Mallinckrodt Medical, Petten, The Netherlands) was 
labeled with " mTc according to the manufacturer’s instruc­
tions. Labeling efficiency as determined by instant thin layer 
chromatography (ITLC) was higher than 95%.
A commercially available kit for tn,lllTc-nanocoll (Solco 
nanocoll, Sorin Biomedica, Vercelli, Italy) was labeled with 
>9mTc according to the manufacturer’s instructions. The particle 
size, as checked by dynamic light scattering, was 8 0 -9 0  nm.
Human, nonspecific polyclonal IgG ( m In-IgG) was conju­
gated to diethylenetriaminepentaacetic bicyclic anhydride (bi- 
cyclic DTPA) as described by Hnatowich et al. (14)  and labeled 
with 11 'in-chloride. Labeling efficiency as determined by ITLC 
was higher than 95%.
Study Design
Biodistribution Studies. Twenty-four hours after S. aureus 
inoculation (15 rats), E. coli inoculation (15 rats) or turpentine
injection (15 rats) in the left calf muscle, the animals were 
injected with 1 MBq of  ,l)mTc-liposomes in the tail vein. 
Analogously, 24 hr after S. aureus inoculation a group o f  15 rats 
was injected with 1 MBq o f  99mTc-IgG. At 2, 8 and 24 hr 
postinjection, five rats o f  each group were killed with 30 mg 
intraperitoneally-injected phénobarbital. Blood was obtained by 
cardiac puncture. Following cervical dislocation, tissues (infect­
ed left calf muscle, right calf muscle, liver, spleen, kidney, 
small bowel, right femur and bone marrow from the right 
femur) were dissected, weighed and their activity was measured 
in a shielded well-type gamma counter. To correct for physical 
decay and to permit calculation o f  the uptake o f  the radiophar­
maceuticals in each organ as a fraction o f  the injected dose, 
aliquots o f  the injected dose were counted simultaneously. 
Abscess-to-muscle and abscess-to-blood ratios were calculated.
Five PCP-infected and five noninfected, weight- and sex- 
matched control rats were injected via the tail vein with a 
mixture o f  1 MBq " mTc-liposornes and 0.4 MBq m In-IgG. 
Twenty-four hours later, all rats were killed with 30 mg 
intraperitoneally-injected phénobarbital. Blood was obtained by 
cardiac puncture. Following cervical dislocation, the lungs and 
a muscle sample from the right calf were obtained, weighed and 
their activity was measured in a shielded well-type gamma 
counter. To correct for physical decay and for contribution o f  
11'in to the 99mTc counts, and to permit calculation o f  the 
uptake o f  the radiopharmaceuticals in the organs as a fraction of 
the injected dose, aliquots o f  the injected doses were counted 
simultaneously. Lung-to-muscle and lung-to-blood ratios were 
calculated.
Imaging Studies. Twenty-four hours after S. aureus infection, 
groups o f  three rats were injected intravenously via the tail vein 
with 10 MBq 99mTc-liposomes, 10 MBq 99mTc-nanocoll or 
10 MBq 99mTc-IgG. Analogously, 24 hr after E. coli infection 
or intramuscular turpentine injection (as described above), 
groups o f  three rats were injected intravenously through the tail 
vein with 10 MBq ggmTc-liposornes.
The rats were anaesthesized with a halothane/nitrousoxide/ 
oxygen mixture and placed prone on a single-head gamma 
camera equipped with a parallel-hole, low-energy collimator. 
Each group o f  rats was imaged at 5 min and 0.75, 2, 4, 6, 10-12 
and 24 hr after injection. Images (300,000 counts per image) 
were obtained and stored in a 256 X  256 matrix.
The scintigrams were analyzed by drawing regions o f  interest 
over the abscess, over the noninfected contralateral calf muscle 
(used as a background region), over the heart (representing 
blood-pool activity) and over the whole animal. Abscess-to- 
background ratios and percentage residual activity in the ab­
scess (abscess-to-whole body ratio) were calculated.
Statistical Analysis
All mean values are given as percent injected dose per gram 
tissue (%ID/g) or ratios ±  1 s.e.m. Statistical analysis was 
performed using one-way analysis of variance (ANOVA). The 
level of significance w'as set at p <  0.05.
RESULTS
Twenty-four hours after injection in the left calf muscle, 
inflammation was observed at inspection and palpation in all 
three models. Turpentine caused the most significant inflam­
matory process: gross swelling and induration without pus 
formation. S. aureus infection caused swelling and induration 
and pus formation. The inflammatory activity caused by E. coli 
infection was the mildest compared to the other two models 
with relatively mild swelling and induration and little pus 
formation.
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FIGURE 1. Images of ""Tc-liposomes at 5 min and 2, 6 and 24 hr after injection in rats with (A) S. aureus infection, (B) E. coli infection or (C 
turpentine-induced inflammation.
Figure l shows the scintigraphic images o f  gt,mTc-liposomes 
at various time points in the three muscle inflammation/ 
infection models. In all models, the abscess was clearly visu­
alized as early as 2 hr postinjection. An over-time increment o f  
the relative uptake in the abscess was noted. Figure 2 shows the 
quantitative analysis o f  the images. There was a steady increase 
o f  the " mTc-liposomes uptake in the abscess (Fig. 2A, 2B). The 
activity in the blood pool (represented by a region o f  interest 
over the heart) showed an initial half life o f  approximately 12 hr 
(Fig. 2C). Over 24 hr, 23.2 ±  0.9 %ID was excreted in urine.
The biodistribution data (Table 1) indicate an increase o f  
activity in the abscess over time occuring in all three models: 
from 2 hr postinjection onwards a significant increase in 
abscess uptake, abscess-to-muscle ratios and abscess-to-blood 
ratios was observed (0.001 <  p <  0.01). Compared to the 
uptake at 2 hr postinjection, absolute uptake in the abscess more 
than doubled, abscess-to-muscle ratios increased more than 
thi *ee-fold, and abscess-to-blood ratios increased more than 
eight-fold. Nevertheless, the abscess uptake o f  gt,mTc-liposomes 
depended on the type o f  focal infection/inflammation. From
2 hr postinjection onwards, WmTc-liposomes uptake in the S. 
aureus and turpentine abscess was significantly higher than that 
in the E. coli abscess (p <  0.01). Turpentine caused a relatively 
rapid accumulation in the abscess: at 8 hr postinjection, the 
abscess uptake was significantly higher in the turpentine ab­
scess compared to the S. aureus abscess (p <  0.01). This 
difference was not observed at 24 hr postinjection. Since normal 
muscle uptake was low throughout the study, abscess-to-muscle 
ratios follow the same pattern as absolute abscess uptake, as 
indicated in Table 1. At 24 hr postinjection, abscess-to-muscle 
ratios in the S. aureus, E. coli and turpentine abscess were as 
high as 41.7 ±  4.1, 24.0 ±  4.5, and 44.5 ±  4.9, respectively. 
Abscess-to-blood ratios were only significantly different at 8 hr 
postinjection: turpentine >  S. aureus >  E. coli (0.001 <  p <  
0.05).
The biodistribution data in Table 2 show relatively low 
activity in liver (1-2 %ID/g) kidneys (2-3 %lD/g), lung (< 1 %  
%ID/g), bone marrow (< 1 %  %ID/g) and bowel (< 0 .5%
%ID/g). The spleen showed relatively high uptake (> 1 2  %ID 
g). When evaluating total organ uptake, liver and spleen 
activity, being the primary target organs for Stealth® liposomes, 
account for the most substantial physiological organ uptake 
(10%—20% ID and 6 % -8 %  ID, respectively).
Technetium-99m-IgG, a clinically used reagent, localized in
S. aureus infection, even at early time points. However, as 
shown in Table 1, abscess uptake decreased over time and 
became significantly lower than lH,nTc-liposomes in the same 
model at 24 hr postinjection (0.49 ±  0.04 %ID/g versus 0.98 ±
0.08 %ID/g, respectively, p <  0.001). As shown in Table 1 
abscess-to-muscle ratios were significantly lower at all time 
points than the respective ratios obtained with WmTc-liposornes 
in the S. aureus model (at 24 hr postinjection, 1 1.8 ±  1.4 and
41.7 ±  4.1, respectively, p <  0.0001). Abscess-to-blood ratios 
were in the same range at all time points, due to faster clearance 
o f  WmTc-IgG from blood and whole body. Technetium-99m- 
IgG cleared faster from the blood pool (initial half life of 
approximately 5 hr) and was more rapidly excreted (over 24 hr. 
49.0 ±  0.8 %ID was excreted in urine). Quantification o f  the 
imaging studies were in line with biodistribution data: after an 
initial increase o f  abscess-to-background ratios, WmTc-IgG is 
washed out from the abscess. Technetium-99m-IgG finally 
showed an abscess-to-background ratio o f  4.9 ±  1.0, compared 
to 11.8 ±  1.0 after WmTc-liposomes injection (p <  0.001). As 
shown in Table 2, the most striking differences in organ 
distribution between liposomes and IgG w'ere the high activity 
in the spleen o f  ^ mTc-liposomes and the high renal uptake of 
WmTc-IgG. Liver, lung, bone marrow and bowel uptake were 
similar.
Despite the similar size compared to the labeled liposomes, 
WmTc-nanocolloid failed to image focal infection. Nanocolloid 
was cleared rapidly from the circulation by the MPS. Abscess- 
to-background ratios, calculated from the scintigrams, were 
very low. Immediately after intravenous injection, the ratios 
were only 1.7 ±  0.1, as a result o f  increased local perfusion. 
Thereafter, the reagent failed to visualize the abscesses. Ab­
scess-to-background ratio decreased to values 1.2. In contrast.
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:IGURE 2. Quantitative analysis (mean ± s.e.m.) of the scintigraphic 
mages of rats injected with 99mTc-liposornes after S. aureus (■) or E. coli (•) 
noculation or intramuscular turpentine (♦) injection. (A) Abscess-to-back- 
jround ratios. (B) Retained activity in the abscess as percentage of residual 
vhole-body activity. (C) Blood clearance, represented by activity in the heart 
egion. Activity measured 5 min postinjection was considered as 100%.
hen using WmTc-liposornes in the S. aureus model, abscess- 
i^-background ratios steadily increase over time and reaching 
alues as high as 1 1.8 ±  1.0 at 24 hr postinjection (p <  0.0001).
In the PCP model, severe P. carinii infestation in the lungs 
v as histologically confirmed. However, no increased WmTc- 
liposomes uptake in the infected lungs could be observed. As 
shown in Table 3, absolute uptake, lung-to-muscle and lung- 
to-blood ratios were nearly identical to the ratios in noninfected 
animals. In contrast, the control agent 111 In-IgG showed signif­
icant accumulation in the infected lungs, compared to nonin­
fected control animals (lung uptake 2.13 ±  0.41 %ID/g versus 
1.02 ±  0.06 %ID/g, respectively, p <  0.01).
DISCUSSION
The present study shows that gw,nTc-labeled Stealth® lipo­
somes accumulate significantly in infectious and inflammatory 
lesions over time. High absolute uptake (up to 1 %ID/g), 
abscess-to-muscle (up to 40) and abscess-to-blood ratios (high­
er than 1) are observed in the various models o f  experimental 
muscle infection and inflammation. Biodistribution showed 
relatively low uptake in other tissues, except for marked splenic 
accumulation (approximately 15% ID/g). This splenic uptake is 
still much lower than that o f  non-PEGylatcd larger liposomes 
(39 %ID/g) (5). Also, bone marrow uptake may be lower for 
Stealth® liposomes (< 1 %  ID/g, for non-PEGylated liposomes 
> 5  %ID/g). Blood clearance and uptake in other organs o f  
Stealth® and non-PEGylated l,WmTc-labcled liposomes arc sim­
ilar (5). Excretion o f  radioactivity is also similar for both 
formulations (23 %ID for Stealth®, 30 %ID for non-PEGylated 
over 24 hr). Overall, targeting o f  the infectious focus with 
l)9mTc-Stealth® liposomes is at least as good or even better than 
that o f  ',l,mTc-non-PEGylated liposomes (two-fold increase o f  
absolute abscess uptake and abscess-to-blood ratios, similar 
abscess-to-muscle ratios). Further improvement may be 
achieved by optimizing size and blood clearance (15).
Labeling Stealth® liposomes with ,,,,mTc or 11'in also causes 
differences. At 24 hr, absolute abscess uptake o f  111 In-lipo­
somes in the S. aureus model is significantly higher compared 
to ,t>mTc-liposomes: 1.93 ±  0.54 %ID/g and 0.98 ±  0.08 
%ID/g, respectively (9).  However, due to different kinetics 
(i.e., faster clearance o f  the l,l>mTc agent from blood and 
background) abscess-to-muscle ratios are two-fold higher for 
l,l,mTc-liposomes and abscess-to-blood ratios are very similar 
(9).  Excretion o f  111 In-liposomes is less than 5% over 24 hr, 
excretion o f  ‘,WmTc-liposornes 23%. In the biodistribution, only 
the very low renal uptake is in favor o f  the 111 In-liposomes (less 
than 1 %ID/g compared to almost 3 %ID/g for ‘,WmTc-lipo- 
somes).
Whether or not this inflammation is induced by a microor­
ganism is irrelevant as illustrated by the accumulation in 
various types o f  muscle inflammation. This indicates that 
infection is not crucial and that the microorganisms are not 
responsible for abscess uptake. The uptake and accumulation o f  
the liposomes appeared to correlate with the intensity o f  
inflammatory response o f  a focus. E. coli infection, with the 
mildest inflammatory response at visual insection and palpa­
tion, shows abscess uptake o f  up to 0.6 %I D/g and abscess-to- 
muscle ratios o f  up to 24. In contrast, the more severe S. aureus 
infection has abscess uptake o f  up to 1.0 %ID/g and abscess- 
to-muscle ratios o f  over 40 at 24 hr after injection. Turpentine- 
induced inflammation causes uptake at least as high as the 
abscess uptake in S. aureus infection.
Apparently, blood clearance is more important than particle 
size for determining accumulation in inflammatory foci. Tech- 
netium-99m-nanocolloid, used in clinical practice for infection 
imaging ( 1 6 ), only showed a mild increase in flow without any 
accumulation in the S. aureus focus. However, size o f  the 
liposomes is an important issue in l,l,mTc-liposomes accumula­
tion. In one control experiment the liposomes were stored at 
4 - 8 ° C  for 3 wk; their size increased to 600 nm during storage. 
These larger liposomes did not show accumulation in E. coli or 
S. aureus abscesses, but were rapidly cleared from circulation. 
Abscess-to-background ratios on the scintigrams were 1.5 or 
lower.
Technetium-99m-liposomes also compared favourably with 
WmTc-IgG, a commercially available radiopharmaceutical for 
imaging infection and inflammation in humans (17) .  Both 
abscess uptake and abscess-to-muscle ratios were significantly 
higher for the labeled liposomes. Important factors are the
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TABLE 1
Abscess, Muscle and Blood Activity (%ID/g ± s.e.m.) and Ratios (± s.e.m.) of Technetium-99m-Liposomes and Technetium-99m-lgG in
Focal Calf Muscle Infection/Inflammation
Time
postinjection
(hr)
99mTc-liposornes 99mTc-lgG
S. aureus E. coli Turpentine S. aureus
Abscess 2 0.45 ± 0.01 0.23 ± 0.02 0.46 ± 0.06 0.68 ± 0.02
8 0.63 ±  0.07 0.36 ± 0.02 0.97 ± 0.06 0.60 ± 0.02
24 0.98 ± 0.08 0.59 ± 0.10 1.18 ± 0.12 0.49 ± 0.04
Muscle 2 0.03 ± 0.001 0.04 ±  0.002 0.04 ± 0.002 0.08 ± 0.01
8 0.03 ±  0.002 0.04 ± 0.002 0.03 ±  0.002 0.06 ± 0.004
24 0.02 ±  0.001 0.03 ± 0.001 0.03 ± 0.001 0.04 ± 0.002
Blood 2 3.40 ± 0.02 2.78 ± 0.11 3.59 ± 0.03 3.04 ± 0.15
8 2.07 ± 0.11 1.89 ± 0.08 1.98 ± 0.12 1.57 ± 0.05
24 0.83 ± 0.04 0.65 ± 0.07 1.11 ±  0.08 0.61 ± 0.02
Abscess-to-muscle 2 13.2 ±0 .5 5.6 ±0 .6 13.0 ±1 .9 8.8 ±1 .0
ratio 8 18.6 ±2 .4 9.0 ±0 .9 40.5 ±5 .0 9.8 ±0 .5
24 41.7 ±4.1 24.0 ±4 .5 44.5 ±4 .9 11.8 ±1 .4
Abscess-to-blood 2 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.2 ±0 .0
ratio 8 0.3 ±0 .0 0.2 ±0 .0 0.5 ±0 .0 0.4 ±0 .0
24 1.2 ±0.1 0.9 ±0.1 1.1 ±0.1 0.8 ±0.1
relatively fast blood and whole-body clearance o f  WmTc-IgG 
due to high renal uptake and urinary excretion. Compared to 
WmTc-liposomes, the initial half life o f  yymTc-IgG in the 
circulation is much shorter (12 versus 5 hr) and the excretion 
over 24 hr two-fold higher (23 %ID versus 49 %ID).
A remarkable aspect o f  WmTc-liposomes is the failure o f  this 
formulation to detect PCP. While m In-IgG, known to be also 
clinically useful for detection of  PCP (/<V), showed significant 
lung uptake in diseased rats, gi)mTc-liposomes uptake did not 
differ from uptake in noninfected controls. However, this is not 
caused by an inability o f  liposomes to target pulmonary 
infection. Previous experiments showed high liposome uptake 
in Klebsiella pneumoniae  lung infection (#). The causative 
microorganism seems to play a key role in this respect. It 
appears that liposomes show a very similar in vivo behavior 
compared to labeled leukocytes. While labeled leukocytes are
excellent for fast detection o f  acute (bacterial) infection o r  
inflammation, they also do not localize in PCP {19) .  Unfortu 
nately, labeled leukocyte scintigraphy is not possible in a rat 
model.
CONCLUSION
When the analogy o f  WmTc-liposomes and WmTc-labeled 
leukocytes is confirmed in terms o f  performance in human 
studies, obvious advantages o f  the liposome formulation would 
be the continuous availability o f  a high-quality radiopharma­
ceutical that can be prepared easily without the need to handle 
blood. In patient care, labeled liposomes would then be an 
attractive agent to replace labeled leukocytes, especially in 
acute infectious disease. Further comparative studies in exper­
imental infection are ongoing.
TABLE 2
Biodistribution of Technetium-99m-Liposomes in Focal Calf Muscle Infection/Inflammation (%ID/g ± s.e.m.)
Time
postinjection
(hr)
""Tc-liposomes ""Tc-IgG
S. aureus E. coli Turpentine S. aureus
Liver 2 2.01 ± 0.32 1.97 ± 0.11 0.79 ± 0.06 1.00 ± 0.08
8 1.94 ± 0.10 1.79 ± 0.21 0.92 ± 0.13 0.76 ± 0.03
24 1.40 ± 0.04 1.32 ± 0.10 0.94 ± 0.13 0.45 ± 0.03
Spleen 2 11.53 ± 1.04 11.53 ±  0.81 18.46 ± 1.21 0.86 ± 0.10
8 13.07 ± 1.79 12.78 ±  0.94 16.86 ± 2.00 0.61 ± 0.02
24 12.49 ± 0.87 10.31 ±  1.22 16.26 ± 1.03 0.38 ± 0.03
Kidney 2 2.05 ± 0.17 2.16 ±  0.11 1.77 ± 0.12 5.72 ± 0.42
8 2.27 ± 0.09 2.57 ± 0.13 1.96 ± 0.07 7.26 ± 0.27
24 3.07 ± 0.08 2.92 ± 0.21 2.51 ± 0.08 7.06 ± 0.70
Lung 2 0.53 ± 0.13 0.79 ± 0.09 0.93 ± 0.05 0.96 ± 0.07
8 0.63 ± 0.07 0.64 ± 0.02 0.52 ± 0.04 0.58 ± 0.01
24 0.35 ± 0.03 0.26 ± 0.02 0.33 ± 0.02 0.32 ± 0.03
Bone marrow 2 0.94 ± 0.24 1.02 ± 0.11 --- 0.85 ± 0.09
8 0.85 ± 0.11 0.41 ± 0.18 --- 0.56 ± 0.04
24 0.32 ± 0.08 0.34 ± 0.05 --- 0.29 ± 0.02
Bowel 2 0.38 ± 0.03 0.34 ± 0.03 0.38 ± 0.04 0.52 ±  0.11
8 0.40 ± 0.05 0.42 ± 0.05 0.38 ± 0.04 0.27 ± 0.02
24 0.37 ± 0.04 0.31 ± 0.02 0.40 ± 0.04 0.15 ± 0.00
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TABLE 3
Pulmonary Uptake (%ID/g ± s.e.m.) and Ratios (± s.e.m.) of Technetium-99m-Liposomes and Indium-111-lgG 24 Hours after Injection
of Pneumocystis Carinii Pneumonia in Rats and Noninfected Controls
9?)mTc-liposornes* 111 ln-lgGr
PCP Noninfected PCP Noninfected
%
Lung uptake 0.98 ± 0.30 0.92 ± 0.08 2.13 ± 0.41 1.02 ± 0.06
Lung-to-blood ratio 0.4 ±0 .0 0.4 ±0 .0 0.7 ±0.1 0.5 ±0 .0
Lung-to-muscle ratio 14.0 ±2 .3 12.7 ±1.5 10.1 ±2 .7 4.3 ±0 .5
*No significant increase in pulmonary ""Tc-liposome uptake and ratios in PCP-infected rats compared to noninfected control animals.
‘Significantly increased pulmonary 111' In-IgG uptake and ratios in PCP-infected rats compared to noninfected control animals (p <  0.01 for all values).
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FIRST IMPRESSIONS: (ERRATUM)
Due to a production error, the images in the July JNM  First Impressions, by Boren et al. 
w ere printed incorrectly. The corrected images and tex t are reprinted below.
PURPOSE
A 71-yr-old man with a history of mild CVA in 1990 presented with 
clinical dementia. The patient was referred for brain SPECT imaging to rule 
out Alzheimer’s disease. Figure 1 shows axial images of the brain with a 
round photopenic defect in the right frontal lobe that extends outside the 
cortex and into the cranium and soft tissues. Figures 2 and 3 depict axial CT 
images through the metal plate and a digital lateral skull film with the metal 
plate clearly demonstrated.
TRACER
Technetium-99m-HMPAO, 32 mCi (884 MBq)
ROUTE OF ADMINISTRATION
Intravenous
TIME AFTER INJECTION
90 minutes
INSTRUMENTATION
Picker Triple-Head Prism 3000 SPECT with ultra-high resolution, fanbeam 
collimation
CONTRIBUTORS
Edwin L. Boren, Jr., Christopher L. Cowan and Shirley G. Anderson 
INSTITUTION
John L. McClellan Memorial Veterans Hospital, Little Rock, Arkansas
Figure 2. Figure 3.
Figure 1.
TECHNETiuM-99m-LiP0S0MES in E xp erim en ta l In fe c tio n  • Oyen et al. 1397
